C
Vertex Pharmaceuticals Incorporated VRTX
$496.49 $2.650.54% NASDAQ
Recommendation
Prev Close
$493.84
Volume
670
Avg Vol (90D)
1,642,432
Market Cap
$126.96B
Dividend & Yield
--
52-Week Range
$377.85 - $519.88
P/E (TTM)
--
EPS (TTM)
-$2.20
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
MaxCyte: Building the Future of Cell and Gene Therapy Innovation
1/23/2025 - MarketBeat
Prosperity Consulting Group LLC Sells 661 Shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)
4/29/2025 - MarketBeat
Johnson Financial Group Inc. Sells 5,283 Shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)
4/29/2025 - MarketBeat
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Shares Sold by Kovitz Investment Group Partners LLC
4/29/2025 - MarketBeat
What is Zacks Research's Estimate for VRTX FY2027 Earnings?
4/29/2025 - MarketBeat
Vertex Pharmaceuticals Takes Over #75 Spot From Comcast
4/28/2025 - The Online Investor
Top Biotech Stocks Worth Watching - April 27th
4/28/2025 - MarketBeat
Vertex Pharmaceuticals (VRTX) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release
4/28/2025 - Zacks Investment Research
California State Teachers Retirement System Sells 11,807 Shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)
4/28/2025 - Ticker Report
Best Biotech Stocks To Watch Now - April 26th
4/27/2025 - MarketBeat
Zacks Research Analysts Boost Earnings Estimates for VRTX
4/27/2025 - MarketBeat
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Shares Purchased by MGO One Seven LLC
4/27/2025 - MarketBeat
Pinebridge Investments L.P. Trims Holdings in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)
4/27/2025 - MarketBeat
Price T Rowe Associates Inc. MD Has $680.85 Million Stock Position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)
4/27/2025 - MarketBeat
Dark Forest Capital Management LP Increases Stock Holdings in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)
4/27/2025 - MarketBeat
Top Biotech Stocks To Watch Now - April 25th
4/26/2025 - MarketBeat
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Shares Sold by Adage Capital Partners GP L.L.C.
4/26/2025 - MarketBeat
Exelixis' Q1 Earnings: Will Cabometyx Maintain Momentum?
4/25/2025 - Zacks Investment Research
CRISPR Therapeutics to Report Q1 Earnings: What's in the Cards?
4/25/2025 - Zacks Investment Research
EMA Backs Vertex Pharmaceuticals' (VRTX) Alyftrek for Cystic Fibrosis Treatment VRTX Stock News
4/25/2025 - GuruFocus
Pinebridge Investments L.P. Cuts Stock Position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)
4/25/2025 - Ticker Report
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Shares Purchased by MGO One Seven LLC
4/25/2025 - Ticker Report
MML Investors Services LLC Has $14.59 Million Stock Position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)
4/25/2025 - MarketBeat
Evercore ISI Keeps Their Buy Rating on Vertex Pharmaceuticals (VRTX)
4/25/2025 - TipRanks Financial Blog
Vertex's Pain Drug: Big Pharma's Next Major Success?
1/16/2025 - MarketBeat
Income Statement
Total Revenue (TTM)
$11.02B
EBITDA (TTM)
$4.77B
EBIT (TTM)
$4.59B
Net Income (TTM)
-$535.60M
Balance Sheet
Total Assets (Q)
$22.53B
Total Debt (Q)
$1.75B
Total Liabilities (Q)
$6.12B
Book Value Per Share (Q)
$63.87
Cash Flow
Cash from Operations (TTM)
-$492.60M
Cash from Investing (TTM)
-$3.77B
Cash from Financing (TTM)
-$1.49B
Net Change in Cash (TTM)
-$5.80B
Filings
Filing Date
Thursday, February 13, 2025
Period Date
Tuesday, December 31, 2024
Next Filing
Week of May 5 and 9 (est)
Price History
Loading...
Beta
0.56
7-Day Total Return
2.18%
30-Day Total Return
-1.64%
60-Day Total Return
13.25%
90-Day Total Return
7.06%
Year to Date Total Return
22.36%
1-Year Total Return
24.91%
2-Year Total Return
53.57%
3-Year Total Return
85.47%
5-Year Total Return
84.91%
52-week Low
Dec 19, 2024 - $377.85
52-week High
Nov 08, 2024 - $519.88
Valuation
Market Cap
$126.96B - Large Cap
Enterprise Value
$117.48B
Price/Sales (TTM)
11.67
Price/Book (Q)
7.73
Dividends and Shares
Shares Outstanding
260.50M
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.vrtx.com
Phone Number
617 341 6100
Address
50 Northern Avenue
Boston, MA 02210
Country
United States
Year Founded
1989
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis (CF). It markets TRIKAFTA/KAFTRIO for people with CF... more
NASDAQ 04/28/2025 4:00PM Eastern Quotes delayed